Supporting Bio-Data Businesses
Every human being has a unique genome, and accordingly, different people need different treatments and drugs for a particular disease. On the other hand, based on these unique characteristics, the susceptibility to diseases also varies from person to person; so that two people may be susceptible to different diseases in exactly the same environmental conditions.
Genome data, which is written as DNA sequences, is an important factor in determining the characteristics of individuals. Personalized medicine has been created based on this concept and with the aim of adapting all stages of care, including prevention, diagnosis and treatment to personal characteristics, needs and functions of individuals.
As a result, it reduces the duration and severity of the disease and improves the success rate in the treatment of diseases. This new approach will also reduce care costs by minimizing the costs associated with ineffective treatment and avoidable side effects. With the help of personalized medicine, the health model focuses from disease treatment to disease prevention and health maintenance.
Pharmacogenomics is one of the most advanced aspects of personalized medicine, which is related to the study of the effect of genetic structure of individuals in determining their response to various drugs. Based on this knowledge, it can be hoped that the type of positive or negative response of patients to a drug can be predicted. This ability can revolutionize the prescription of safer and more effective drugs alongside treatment and its economy.